A retrospective, multicenter cohort study evaluating the efficacy of ustekinumab in patients with Crohn's Disease of the pouch and chronic pouchitis
Latest Information Update: 03 Mar 2020
Price :
$35 *
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease; Pouchitis
- Focus Therapeutic Use
- 03 Mar 2020 New trial record